ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 129 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $65,000 | +3.2% | 44,702 | 0.0% | 0.00% | – |
Q4 2016 | $63,000 | -14.9% | 44,702 | +5.6% | 0.00% | – |
Q3 2016 | $74,000 | +2.8% | 42,345 | 0.0% | 0.00% | – |
Q2 2016 | $72,000 | -13.3% | 42,345 | 0.0% | 0.00% | – |
Q1 2016 | $83,000 | +6.4% | 42,345 | +3.4% | 0.00% | – |
Q4 2015 | $78,000 | 0.0% | 40,950 | 0.0% | 0.00% | – |
Q3 2015 | $78,000 | -53.8% | 40,950 | +12.2% | 0.00% | – |
Q2 2015 | $169,000 | -1.2% | 36,495 | -6.2% | 0.00% | – |
Q1 2015 | $171,000 | +39.0% | 38,912 | +10.2% | 0.00% | – |
Q4 2014 | $123,000 | -35.6% | 35,326 | -22.6% | 0.00% | – |
Q3 2014 | $191,000 | -28.7% | 45,658 | 0.0% | 0.00% | – |
Q2 2014 | $268,000 | -39.9% | 45,658 | -35.5% | 0.00% | -100.0% |
Q1 2014 | $446,000 | +26.3% | 70,753 | +17.3% | 0.00% | 0.0% |
Q4 2013 | $353,000 | -6.4% | 60,330 | -15.6% | 0.00% | 0.0% |
Q3 2013 | $377,000 | -17.3% | 71,459 | +20.6% | 0.00% | 0.0% |
Q2 2013 | $456,000 | – | 59,230 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 1,952,891 | $2,852,000 | 0.72% |
Nine Chapters Capital Management LLC | 180,200 | $263,000 | 0.36% |
Camber Capital Management LP | 4,250,000 | $6,205,000 | 0.25% |
TFS CAPITAL LLC | 340,092 | $497,000 | 0.16% |
ASCEND CAPITAL, LLC | 1,008,949 | $1,473,000 | 0.07% |
Acrospire Investment Management LLC | 39,781 | $58,000 | 0.05% |
OXFORD ASSET MANAGEMENT LLP | 1,081,912 | $1,580,000 | 0.04% |
Jacobi Capital Management LLC | 35,000 | $49,000 | 0.02% |
Renaissance Technologies | 8,479,445 | $12,380,000 | 0.02% |
A.R.T. Advisors, LLC | 238,036 | $347,000 | 0.02% |